Prostate Cancer
Racial and Ethnic Trends in Prostate Cancer Incidence and Mortality in Philadelphia, PA: an Observational Study.
December 11, 2018
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
December 11, 2018
Serum Neuroendocrine Markers Predict Therapy Outcome of Patients with Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis.
December 10, 2018
Cost-effectiveness analyses and cost analyses in castration-resistant prostate cancer: A systematic review.
December 10, 2018
Prospective Evaluation of Chondroitin Sulfate, Heparan Sulfate and Hyaluronic Acid in Prostate Cancer.
December 10, 2018
Levels and patterns of self-reported and objectively-measured free-living physical activity among prostate cancer survivors: A prospective cohort study.
December 10, 2018
BCAR4 activates GLI2 signaling in prostate cancer to contribute to castration resistance.
December 7, 2018
Non-invasive quantification of tumor blood flow in prostate cancer using 15O-H2O PET/CT.
December 7, 2018
Deletion of 3p13 is a late event linked to progression of TMPRSS2:ERG fusion prostate cancer.
December 7, 2018
Salvage Lymph Node Dissection for Nodal Recurrent Prostate Cancer: A Systematic Review.
December 7, 2018
Cyclohexanone curcumin analogs inhibit the progression of castration resistance prostate cancer in vitro and in vivo.
December 6, 2018
Targeting genotoxic and proteotoxic stress-response pathways in human prostate cancer by clinically available PARP inhibitors, vorinostat and disulfiram.
December 6, 2018
Specific and reliable detection of Myosin 1C isoform A by RTqPCR in prostate cancer cells.
December 6, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
December 6, 2018
M2 macrophages and regulatory T cells in lethal prostate cancer.
December 5, 2018